High density lipoprotein mimicking nanoparticles for atherosclerosis.

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Nanotechnology

Background:

• Atherosclerosis is a primary cause of global mortality, contributing to myocardial infarction, ischemic stroke, and peripheral arterial disease.
• High-density lipoproteins (HDL), or "good cholesterol", exhibit anti-atherosclerotic properties by facilitating cholesterol removal from plaque foam cells.

Purpose of the Study:

• To review recent progress in the development of HDL-mimicking nanoparticles (NPs).
• To summarize the applications of these HDL-mimicking NPs in imaging, targeting, and treating atherosclerosis.

Main Methods:

• Literature review of recent advancements in HDL-mimicking nanoparticle design.
• Analysis of studies focusing on the application of these nanoparticles in atherosclerosis.

Main Results:

• Significant progress has been made in designing functional HDL-mimicking NPs.
• These NPs show potential for various applications in atherosclerosis management.

Conclusions:

• HDL-mimicking NPs represent a promising therapeutic avenue for atherosclerosis.
• Further development and application of these NPs are crucial for combating cardiovascular disease.